摘要
目的探讨计算机断层扫描(CT)引导下碘125粒子植入术治疗肺癌临床疗效和安全性。方法入组2014年4月至2018年4月在我院进行治疗的肺癌患者80例作为研究对象,均采用CT引导下碘125粒子植入术治疗,观察并记录所有患者的治疗效果和不良反应。结果80例肺癌患者共置入碘125粒子4880粒,平均手术时间为65min。治疗3个月后疾病控制率为96.25%,治疗6个月后疾病控制率为100.00%。全组不良反应发生率为31.25%,经过对症治疗均得到缓解。结论对于肺癌患者,采用CT引导下碘125粒子植入术治疗,具有显著治疗效果,且不良反应发生率较低,有助于促进患者恢复,从而改善患者的生活质量,值得临床推广运用。
Objective To investigate the effect of iodinated-125 seed implantation guided by computed tomography (CT) in the treatment of patients with lung cancer. Methods Eighty cases of lung cancer treated in our hospital from April 2014 to April 2018 were selected as the research subjects. All the 80 subjects were treated with iodine-125 seed implantation guided by CT, and the therapeutic effect and adverse reaction were observed. Results The 4 880 particles of iodine-125 seeds were implanted in the study. The average operation time was 65 min. The disease control rate was 96.25% after 3 months of treatment. The disease control rate was 100.00% after 6 months treatment. The incidence of adverse reaction was 31.25% during the treatment period, and all the adverse reaction were relieved after symptomatic treatment. Conclusion For the patients with lung cancer, iodide-125 seed implantation guided by CT has significant therapeutic effect, and the incidence of adverse reaction is low. It is helpful to promote the recovery of patients and improve the quality of life of the patients, which is worthy of clinical application.
作者
梁志华
LIANG Zhihua(Department of Medical Imaging,Zhengzhou People’s Hospital,Zhengzhou 450003,China)
出处
《肿瘤基础与临床》
2019年第3期214-216,共3页
journal of basic and clinical oncology
